February 23, 2024
Genome British Columbia is pleased to announce the appointment of Steven Zicherman to our Board of Directors
Steven Zicherman is an Equity Analyst at Odlum Brown Limited. He has over 20 years of experience providing analytical coverage for various market sectors, including information technology and health care. Mr. Zicherman has a Bachelor of Arts degree in Statistics from the University of Western Ontario, an MBA from Dalhousie University and is a Chartered Financial Analyst (CFA) charterholder.
Steven Zicherman, Director and Equity Analyst at Odlum Brown Limited, has been appointed to Genome BC’s Board of Directors.
“I am delighted to join Genome British Columbia’s Board,” said Zicherman. Every day, we’re seeing how genomics is making a real difference in our lives. Whether it’s improving healthcare or transforming industries like forestry and agriculture, we’re tackling big challenges in smart, sustainable ways. Genomics is a field full of possibilities, where each advancement opens doors to previously unimagined opportunities for progress and innovation. I’m excited to contribute to Genome British Columbia’s mission to use genomics to make life better for people in British Columbia.”
Genome BC has been a leading organization for over 20 years, investing more than $1.3 billion in more than 525 genomics research and innovation projects. These initiatives advance health care and also address environmental and natural resource challenges, improving the lives of people across BC.
In addition to scientific programming, Genome BC integrates genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public.
